|
Mar 14
|
Nyxoah SA (NYXH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic US ...
|
|
Mar 13
|
Nyxoah SA (NYXH) Reports Q4 Loss, Lags Revenue Estimates
|
|
Mar 13
|
Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results
|
|
Mar 10
|
Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025
|
|
Mar 3
|
Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
|
|
Feb 14
|
Hims & Hers Health (HIMS) Surges 27.7%: Is This an Indication of Further Gains?
|
|
Jul 29
|
Nyxoah to Release Second Quarter and First Half 2024 Financial Results on August 6, 2024
|
|
Dec 11
|
Nyxoah Announces Real World Case Series Demonstrating Positive Results in Treating CCC Patients with Genio®
|
|
Dec 8
|
Publication Relating to a Transparency Notification
|
|
Nov 28
|
Nyxoah Strengthens its Executive Leadership Team
|
|
Sep 28
|
Nyxoah Announces Partnership with ResMed in Germany
|
|
Aug 8
|
Nyxoah SA (NYXH) Reports Q2 Loss, Tops Revenue Estimates
|
|
Aug 8
|
Nyxoah Reports Second Quarter and First Half 2023 Financial and Operating Results
|